Global Contract Development and Manufacturing Organizations (CDMOs) Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14763621 | Publishing Date : 26-Sep-2019 | No. of pages : 130
A contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
Lonza was the global largest company in Contract Development and Manufacturing Organizations (CDMOs) industry,with the Revenue Share of 4.80% in 2018,followed by Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics, AMRI, Famar, WuXi AppTech, Asymchem, Porton, Amatsigroup.
In 2018, the global Contract Development and Manufacturing Organizations (CDMOs) market size was 66550 million US$ and it is expected to reach 128630 million US$ by the end of 2025, with a CAGR of 10.0% during 2019-2025.
This report focuses on the global Contract Development and Manufacturing Organizations (CDMOs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Contract Development and Manufacturing Organizations (CDMOs) development in North America, Europe, China and India.
Lonza
Catalent
Patheon (Thermo Fisher Scientific)
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup
API Development
Manufacturing
Drug Delivery
API Development had a revenue share of 47% in 2018,followed by manufacturing and drug delivery.
Pharmaceutical Company
Biotechnology Company
Generic Company
Pharmaceutical Company is the largest segment of Contract Development and Manufacturing Organizations (CDMOs) application,with a share of 53.4% in 2018.
North America
Europe
China
India
To analyze global Contract Development and Manufacturing Organizations (CDMOs) status, future forecast, growth opportunity, key market and key players.
To present the Contract Development and Manufacturing Organizations (CDMOs) development in North America, Europe, China and India.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Contract Development and Manufacturing Organizations (CDMOs) are as follows:
History Year: 2014-2018
2018
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Lonza was the global largest company in Contract Development and Manufacturing Organizations (CDMOs) industry,with the Revenue Share of 4.80% in 2018,followed by Catalent, Patheon (Thermo Fisher Scientific), Aenova, Siegfried, Recipharm, Strides Shasun, Piramal, Metrics, AMRI, Famar, WuXi AppTech, Asymchem, Porton, Amatsigroup.
In 2018, the global Contract Development and Manufacturing Organizations (CDMOs) market size was 66550 million US$ and it is expected to reach 128630 million US$ by the end of 2025, with a CAGR of 10.0% during 2019-2025.
This report focuses on the global Contract Development and Manufacturing Organizations (CDMOs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Contract Development and Manufacturing Organizations (CDMOs) development in North America, Europe, China and India.
The key players covered in this study
Lonza
Catalent
Patheon (Thermo Fisher Scientific)
Aenova
Siegfried
Recipharm
Strides Shasun
Piramal
Metrics
AMRI
Famar
WuXi AppTech
Asymchem
Porton
Amatsigroup
Market segment by Type, the product can be split into
API Development
Manufacturing
Drug Delivery
API Development had a revenue share of 47% in 2018,followed by manufacturing and drug delivery.
Market segment by Application, split into
Pharmaceutical Company
Biotechnology Company
Generic Company
Pharmaceutical Company is the largest segment of Contract Development and Manufacturing Organizations (CDMOs) application,with a share of 53.4% in 2018.
Market segment by Regions/Countries, this report covers
North America
Europe
China
India
The study objectives of this report are:
To analyze global Contract Development and Manufacturing Organizations (CDMOs) status, future forecast, growth opportunity, key market and key players.
To present the Contract Development and Manufacturing Organizations (CDMOs) development in North America, Europe, China and India.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Contract Development and Manufacturing Organizations (CDMOs) are as follows:
History Year: 2014-2018
Base Year:
2018Estimated Year:
2019Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.